Weight-loss medications are everywhere right now. GLP-1 medications like Ozempic®, Wegovy®, Mounjaro®, and Zepbound® have changed the conversation around weight, appetite, blood sugar, and long-term health.
But for women who already deal with bladder leaks, pads, urgency, or recurring UTIs, these medications can raise another question: Could my medication be affecting my bladder health?
The answer is not as simple as “weight-loss drugs cause UTIs.” In fact, one of the most common misunderstandings is mixing up GLP-1 medications with a different class of diabetes drugs called SGLT2 inhibitors.
That distinction matters, especially if you are noticing more urinary symptoms, more pad use, or more concern about infections.
Do Weight-Loss Medications Cause UTIs?
Current evidence does not support a simple claim that GLP-1 weight-loss medications directly cause UTIs by putting glucose into the urine.
GLP-1 medications include drugs such as semaglutide and tirzepatide, sold under brand names like Ozempic, Wegovy, Mounjaro, and Zepbound. These medications work through hormone pathways involved in appetite, digestion, insulin response, and blood sugar control. They are not designed to make the body release glucose into the urine.
That “sugar in the urine” issue is more closely tied to a different class of diabetes medications called SGLT2 inhibitors. SGLT2 inhibitors include medications such as Jardiance®, Farxiga®, Invokana®, and Steglatro®. These medications work through the kidneys by helping remove glucose from the body through urine. FDA information for Farxiga describes dapagliflozin as an SGLT2 inhibitor that works by reducing glucose and sodium reabsorption in the kidneys.1
In other words, increased glucose in urine is part of how SGLT2 inhibitors work. So if someone says, “My medication is making sugar show up in my urine,” they may be talking about an SGLT2 inhibitor, not a GLP-1 medication.
The better question is not simply, “Do weight-loss drugs cause UTIs?” The better question is: If you are taking weight-loss medication, diabetes medication, or both, and your bladder symptoms are changing, what else might be going on?
The answer could involve blood sugar, hydration, constipation, menopause-related changes, pelvic floor weakness, an actual UTI, an SGLT2 medication, or more than one factor at the same time.
Why Glucose in Urine Can Matter
Glucose in the urine can matter because bacteria and yeast may grow more easily when excess sugar is present.
The CDC notes that women with diabetes have a higher risk of urinary tract infections. The CDC also explains that when blood sugar is high, some women may release excess sugar in their urine, which can encourage yeast and bacteria to grow.2
This does not mean every woman with diabetes will get UTIs. It also does not mean that glucose in urine is the only reason UTIs happen. But it does help explain why diabetes, urinary symptoms, and infection concerns are so closely connected.
For women who leak urine, there is another practical issue: urine does not always go straight into the toilet. It may end up in a pad, underwear, clothing, or against the skin. If leaks are frequent, that can mean more moisture, more odor concerns, more irritation, and more pad changes throughout the day.
That is where the concern about “glucose on pads” may come from.
It is not accurate to say that GLP-1 weight-loss drugs cause sugary pads and UTIs. But it is reasonable to say that some diabetes-related situations can increase glucose in urine, and for women who also leak urine, that urine may sit against the skin or pad longer than intended.
A more accurate way to frame it is this: diabetes, high blood sugar, and certain diabetes medications can affect urine and infection risk. If you also have bladder leaks, pads, moisture, and irritation can add another layer to the problem.
Diabetes and Bladder Health
Medication is only part of the story. Diabetes itself can affect bladder health.
Over time, diabetes can contribute to bladder problems by affecting nerves, bladder sensation, and bladder emptying. The National Institute of Diabetes and Digestive and Kidney Diseases explains that many people with diabetes may have trouble emptying the bladder completely. When urine stays in the bladder too long, also called urinary retention, it can contribute to bladder infections, urine leaks, and the feeling that you always have to go.3
That means diabetes can be connected to bladder symptoms in several ways. High blood sugar may increase urination and thirst. Glucose in urine may encourage yeast or bacteria to grow. Nerve changes may affect how well the bladder empties. Urinary retention may increase the risk of infection. Bladder infections may worsen urgency, frequency, and leakage.
For many women, the result is not one single symptom. It is a frustrating cycle: more urgency, more leaks, more pads, more irritation, and more concern about UTIs.
SGLT2 inhibitors can add another layer to that conversation. These medications have important benefits for many people with type 2 diabetes, heart failure, or kidney disease. But because they increase glucose in the urine, they are also associated with genitourinary infection concerns.
FDA prescribing information for Farxiga states that treatment with SGLT2 inhibitors increases the risk for urinary tract infections and advises clinicians to evaluate patients for UTI signs and symptoms.4
The research picture is somewhat nuanced. Some studies and reviews suggest the risk increase is clearer for genital infections than for UTIs, and that the overall benefits of SGLT2 inhibitors often outweigh the infection risks for appropriate patients.5
From a patient’s point of view, the practical takeaway is simple: if you are taking an SGLT2 inhibitor and notice burning, urgency, odor, irritation, yeast symptoms, or sudden changes in bladder control, it is worth contacting your healthcare provider. Do not stop a prescribed diabetes medication without medical guidance, but do ask questions, especially if urinary symptoms are new or getting worse.
Pads, Leaks, and Daily Burden
A UTI can sometimes feel like a sudden loss of bladder control. Women may notice urgency, frequency, burning, pelvic discomfort, cloudy urine, strong-smelling urine, or new leakage.
NIDDK lists common bladder infection symptoms including burning during urination, frequent urges to urinate, lower abdominal pain or discomfort, and cloudy, bloody, or strong-smelling urine.6
For women who already have incontinence, a UTI can make symptoms feel dramatically worse. A woman who usually leaks a little with coughing, laughing, or exercise may suddenly feel like she cannot make it to the bathroom. Someone who already has urgency may feel like her bladder is in constant overdrive.
That is why new or suddenly worse bladder symptoms should not be brushed off as “just leaks.” If symptoms come with pain, burning, fever, blood in the urine, back pain, or feeling sick, contact a healthcare provider.
Elitone is not a UTI treatment. UTIs require medical evaluation and, when appropriate, medication. But if infections are being ruled out and leaks are still happening, then the leakage itself deserves attention.
Pads can be helpful. They provide backup, confidence, and protection from accidents. But pads do not treat the reason leakage is happening.
And when pad use becomes daily or constant, it can create its own burden. Pads can mean moisture against the skin, odor worries, extra laundry, clothing choices based on leaks, planning around bathrooms, and ongoing expense.
For women with diabetes or UTI concerns, the pad issue may feel even more frustrating. If you are worried about urine, moisture, irritation, or infections, relying on pads all day may not feel like enough.
That is the point where it may be time to ask a different question: Instead of only managing leaks after they happen, can you reduce the leaks in the first place?